Despite advances in interventional technology, the incidence of postprocedural cardiac marker elevation has not substantially decreased since the first serial assessment 20 years ago. As of now, these postprocedural cardiac marker elevations are considered to represent periprocedural myocardial injury (PMI) with worse long-term outcome potential.
|Title of host publication||Bioresorbable Scaffolds|
|Subtitle of host publication||From Basic Concept to Clinical Applications|
|Number of pages||7|
|Publication status||Published - 01-01-2017|
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)